As an oncology diagnostics executive with Fulgent Genetics, Ms. Patricia Murphy is responsible for leading the company’s oncology precision diagnostics division. Ms. Murphy employed her extensive knowledge of the US and global health care systems, as well as her oncology business domain expertise and insight - acquired through a successful career in the business expanding over 25 years - to launch this segment for the organization. As an integral leader in the launch of Fulgent Oncology in June of 2022, Ms. Murphy personally led every aspect of the commercial launch of the company's Lumera™ Oncology portfolio, which includes Comprehensive Genomic Profiling (CGP) NGS products for Solid Tumor, as well as Liquid Biopsy (ctDNA) assays, as well as complementing the offering by incorporating the legacy menu of Hereditary Oncology profiles and assays from Fulgent Genetics' existing germline menu. In addition to the somatic CGP and germline product lines, Ms. Murphy oversaw the successful commercial merger of the hematopathology portfolio from the Inform Diagnostics' business unit, acquired by Fulgent in 2022. By successfully merging these two oncology commercial business units, Ms. Murphy's commercial leadership led Fulgent Oncology to becoming one of the most comprehensive offerings in the community oncology segment nationwide.

Prior to becoming the VP of Oncology Sales and Head of Precision Diagnostics at Fulgent Genetics. Ms. Murphy held successful sales leadership roles at Labcorp Oncology, Siemens Healthineers and SkylineDx, which is based in Rotterdam (the Netherlands). These roles led to forward strategies and sustained growth in the areas of clinical trials partnerships, GPO-driven growth strategies, diagnostic instrumentation negotiations, novel LDT early-adoption and channel distribution, as well as RFP's with state, county and VA clients. As a commercial leader in these positions, she has had direct responsibility in diagnostics and oncology marketing, brand management, sales operations, market access strategies and MolDx submissions, clinical trial management, KOL and IDN management, as well as extensive 1st and 2nd line sales leadership experience.

From 2010 to 2016, Ms. Murphy held progressive sales leadership roles at Quest Diagnostics, Inc., the largest commercial laboratory in the world. As a District Sales Manager, Area Sales Director, and later as International Commercial Director assigned to the Latin American Business Unit based in Mexico City, MX, she successfully managed and executed growth strategies for a variety of diagnostic market segments that covered physicians, hospitals, reference laboratories, pharmaceutical company projects and government institutions. Ms. Murphy's success was recognized at Quest with President's Club and CEO TOP 10% Awards, as well as the recognition of being selected to be a part of the exclusive Quest Leadership program in 2012-2013, a cohort of 30-40 leaders recognized as exceptional and instrumental for the future of the organization.

Throughout her career, Ms. Murphy has earned multiple President's Club Awards, both as an individual contributor, as well as a sales leader. She has been recognized by her peers, professional network, the teams she has led, and also her clients as a dedicated and committed servant leader, passionate in the pursuit to improve patients lives and disease outcomes by delivering powerful diagnostic solutions to the market.

Ms. Patricia Murphy holds an MBA with a concentration in healthcare business from California Baptist University. As part of her capstone, she completed Healthcare Systems studies in Asia, with coursework completed abroad in Singapore and Malaysia. She holds a BA in Management from the University of Redlands and is currently a PhD candidate, working to earn a doctorate in Organizational Leadership at California Baptist University. In her free time, Patricia enjoys time spent with her husband Kevin and her four adult children, as well as her extended family and longtime friends. She is avid swimmer and enjoys downhill skiing, as well as traveling to different countries and learning various cultures and customs as a global citizen.

Patricia V Murphy